|
Mar 18
|
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer
|
|
Mar 15
|
Delcath Systems Announces $7 Million Private Placement
|
|
Mar 8
|
Delcath Systems to Participate in Upcoming Investor Conferences
|
|
Jan 16
|
Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™
|
|
Jan 12
|
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Dec 7
|
Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research
|
|
Nov 6
|
Delcath Systems to Host Third Quarter 2023 Results Call
|
|
Sep 27
|
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|